Standard Contracts
July 5, 2019 Immuno-Oncology Clinic, Inc. El Segundo California 90245 Ladies and Gentlemen:Clinical Trial Agreement • August 6th, 2019 • NantKwest, Inc. • Biological products, (no disgnostic substances) • California
This letter agreement (this “Letter Agreement”), effective as of July 1, 2019 (the “Effective Date”), confirms the rights and obligations of Immuno-Oncology Clinic, Inc. (the “Clinic”) and NantKwest, Inc. (“Nant”) with respect to certain clinical trials that Nant desires to conduct at the Clinic. Tara Seery, MD and Chaitali Nangia, MD (together, “Investigators”), while not parties hereto, are nevertheless executing this Letter Agreement to acknowledge that they have read and understood this Letter Agreement in its entirety and agree to comply with the terms and conditions hereof.
